5,7-dihydroxytryptamine has been researched along with endomorphin 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hung, KC; Leitermann, R; Mizoguchi, H; Tseng, LF; Wu, HE | 1 |
1 other study(ies) available for 5,7-dihydroxytryptamine and endomorphin 1
Article | Year |
---|---|
Intrathecal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine blocks the antinociception induced by endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse.
Topics: 5,7-Dihydroxytryptamine; Analgesics; Animals; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Spinal; Male; Mice; Oligopeptides; Oxidopamine; Pain Measurement | 2003 |